136 related articles for article (PubMed ID: 32182949)
1. Can Comprehensive Geriatric Assessment Predict Tolerance of Radiotherapy for Localized Prostate Cancer in Men Aged 75 Years or Older?
Goineau A; Campion L; Commer JM; Vié B; Ghesquière A; Béra G; Jaffres D; Magné N; Artignan X; Chamois J; Bergerot P; Créhange G; Deniaud-Alexandre E; Buthaud X; Belkacémi Y; Doré M; De Decker L; Supiot S
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32182949
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Geriatric Assessment and quality of life after localized prostate cancer radiotherapy in elderly patients.
Goineau A; Campion L; d'Aillières B; Vié B; Ghesquière A; Béra G; Jaffres D; de Laroche G; Magné N; Artignan X; Chamois J; Bergerot P; Martin E; Créhange G; Deniaud-Alexandre E; Buthaud X; Belkacémi Y; Doré M; de Decker L; Supiot S
PLoS One; 2018; 13(4):e0194173. PubMed ID: 29630602
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Geriatric Assessment in Men Aged 70 Years or Older with Localised Prostate Cancer Undergoing Radical Radiotherapy.
Osborne GEC; Appleyard SA; Gilbert DC; Jones CI; Lorimer C; Villanueva M; Peasgood E; Robinson A; Nikapota A; Ring A
Clin Oncol (R Coll Radiol); 2017 Sep; 29(9):609-616. PubMed ID: 28592379
[TBL] [Abstract][Full Text] [Related]
4. Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial.
Nabid A; Carrier N; Martin AG; Bahary JP; Lemaire C; Vass S; Bahoric B; Archambault R; Vincent F; Bettahar R; Duclos M; Garant MP; Souhami L
Eur Urol; 2018 Oct; 74(4):432-441. PubMed ID: 29980331
[TBL] [Abstract][Full Text] [Related]
5. Regeneration of older patients after oncologic surgery. A temporal trajectory of geriatric assessment and quality of life parameters.
Deschler B; Ihorst G; Hüll M; Baier P
J Geriatr Oncol; 2019 Jan; 10(1):112-119. PubMed ID: 30314954
[TBL] [Abstract][Full Text] [Related]
6. Impact of comprehensive geriatric assessment on quality of life, overall survival, and unplanned admission in patients with non-small cell lung cancer treated with stereotactic body radiotherapy.
Jeppesen SS; Matzen LE; Brink C; Bliucukiene R; Kasch S; Schytte T; Kristiansen C; Hansen O
J Geriatr Oncol; 2018 Nov; 9(6):575-582. PubMed ID: 29871849
[TBL] [Abstract][Full Text] [Related]
7. Independence and health related quality of life in 200 onco-geriatric surgical patients within 6 months of follow-up: Who is at risk to lose?
Baier P; Ihorst G; Wolff-Vorbeck G; Hüll M; Hopt U; Deschler B
Eur J Surg Oncol; 2016 Dec; 42(12):1890-1897. PubMed ID: 27519617
[TBL] [Abstract][Full Text] [Related]
8. Predictors of depression, anxiety and quality of life in patients with prostate cancer receiving androgen deprivation therapy.
Chipperfield K; Fletcher J; Millar J; Brooker J; Smith R; Frydenberg M; Burney S
Psychooncology; 2013 Oct; 22(10):2169-76. PubMed ID: 23483679
[TBL] [Abstract][Full Text] [Related]
9. A pilot study of the vulnerable elders survey-13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablation.
Mohile SG; Bylow K; Dale W; Dignam J; Martin K; Petrylak DP; Stadler WM; Rodin M
Cancer; 2007 Feb; 109(4):802-10. PubMed ID: 17219443
[TBL] [Abstract][Full Text] [Related]
10. Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial.
Denham JW; Joseph D; Lamb DS; Spry NA; Duchesne G; Matthews J; Atkinson C; Tai KH; Christie D; Kenny L; Turner S; Gogna NK; Diamond T; Delahunt B; Oldmeadow C; Attia J; Steigler A
Lancet Oncol; 2019 Feb; 20(2):267-281. PubMed ID: 30579763
[TBL] [Abstract][Full Text] [Related]
11. Use of androgen deprivation therapy as salvage treatment after primary therapy for clinically localized prostate cancer.
Fu AZ; Tsai HT; Haque R; Ulcickas Yood M; Van Den Eeden SK; Cassidy-Bushrow AE; Zhou Y; Keating NL; Smith MR; Aaronson DS; Potosky AL
World J Urol; 2016 Dec; 34(12):1611-1619. PubMed ID: 27084777
[TBL] [Abstract][Full Text] [Related]
12. Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy.
Lilleby W; Fosså SD; Waehre HR; Olsen DR
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(4):735-43. PubMed ID: 10098428
[TBL] [Abstract][Full Text] [Related]
13. [Cancer treatment in elderly patients: evidence and clinical research].
Repetto L; Luciani A
Recenti Prog Med; 2015 Jan; 106(1):23-7. PubMed ID: 25621776
[TBL] [Abstract][Full Text] [Related]
14. Quality of life decrements in men with prostate cancer undergoing androgen deprivation therapy.
Cheung AS; de Rooy C; Hoermann R; Lim Joon D; Zajac JD; Grossmann M
Clin Endocrinol (Oxf); 2017 Mar; 86(3):388-394. PubMed ID: 27696495
[TBL] [Abstract][Full Text] [Related]
15. No impairment of quality of life 18 months after high-dose intensity-modulated radiotherapy for localized prostate cancer: a prospective study.
Marchand V; Bourdin S; Charbonnel C; Rio E; Munos C; Campion L; Bonnaud-Antignac A; Lisbona A; Mahé MA; Supiot S
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1053-9. PubMed ID: 19880259
[TBL] [Abstract][Full Text] [Related]
16. Quality of life in geriatric oncology--An evaluation of standard questionnaires in elderly men with urological malignancies.
Terret C; Pérol D; Albrand G; Droz JP
Crit Rev Oncol Hematol; 2011 Mar; 77(3):201-9. PubMed ID: 20338777
[TBL] [Abstract][Full Text] [Related]
17. Prospective assessment of the quality of life before, during and after image guided intensity modulated radiotherapy for prostate cancer.
Sveistrup J; Mortensen OS; Bjørner JB; Engelholm SA; Munck Af Rosenschöld P; Petersen PM
Radiat Oncol; 2016 Sep; 11(1):117. PubMed ID: 27604898
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of self-estimation of disuric disorders gauged IPSS scale and qualities of lives QoL with self-estimation of sexual life gauged by IIEF-5 scale].
Lipczyński W; Dobrowolska-Glazar B; Dobrowolski ZF
Przegl Lek; 2012; 69(6):247-52. PubMed ID: 23094437
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Frailty Syndrome in Men with Metastatic Prostate Cancer: A Scoping Review.
Mafla-España MA; Torregrosa MD; Cauli O
J Pers Med; 2023 Feb; 13(2):. PubMed ID: 36836553
[TBL] [Abstract][Full Text] [Related]
20. Combined Long-Term Androgen Deprivation and Pelvic Radiotherapy in the Post-operative Management of Pathologically Defined High-Risk Prostate Cancer Patients: Results of the Prospective Phase II McGill 0913 Study.
Kucharczyk MJ; Tsui JMG; Khosrow-Khavar F; Bahoric B; Souhami L; Anidjar M; Probst S; Chaddad A; Sargos P; Niazi T
Front Oncol; 2020; 10():312. PubMed ID: 32226774
[No Abstract] [Full Text] [Related]
[Next] [New Search]
